Yubo International Biotech Limited
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-247.9K | $-272.6K | $-103.1K | $-310.2K | $-230.3K | $-435.6K | $-249.8K | $-621.1K |
| Depreciation & Amortization | $793 | $25.7K | $42.3K | $41.9K | $41.7K | $41.6K | $39.2K | $46.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $162 | $3.3K | $1.7K | $1.7K | $3.4K | $3.4K | $3.2K | $3.6K |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-84.1K | $-207.2K | $-128.8K | $-308.0K | $-14.0K | $-392.0K | $-932.7K | $353.3K |
| Investing Activities | ||||||||
| Capital Expenditures | — | $0 | — | — | — | $6.2K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $-79.9K | $0 | $86.1K | $-6.2K | $0 | $36.5K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $77.2K | $214.5K | $375.6K | $0 | $196.1K | $277.8K | $1.1M | $-420.6K |
| Net Change in Cash | $1.6K | $2.3K | $-2.9K | $510 | $643 | $2.8K | $-1.0K | $-4.7K |
| Free Cash Flow | — | $-207.2K | — | — | — | $-398.2K | — | — |